Zacks Consensus Estimate This world's largest biotech drugmaker is expected to post quarterly earnings of $3.68 per share in its upcoming report, which represents a year-over-year change of -7.3%.Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.